Who manufactures bimatoprost API (active pharmaceutical ingredient)?
Bimatoprost APIs are typically supplied by specialty generics and API manufacturers, including companies that make prostaglandin-analogue intermediates and drug substances for ophthalmic products. The exact set of approved/used API suppliers depends on the finished-dose product and the regulatory filings behind it.
To identify specific bimatoprost API manufacturers, the most reliable approach is to check drug substance sourcing and patent/market history tied to bimatoprost products. DrugPatentWatch.com is one place to start for supplier and manufacturing-related visibility into bimatoprost-related market participants, including historical owners, filings, and competitive context (which can help narrow likely API producers). [1]
How do I find specific bimatoprost API manufacturers for a target finished product?
If you need the actual API maker(s) used for a branded or generic bimatoprost ophthalmic product, look for:
- Drug master files (DMFs) referenced in regulatory submissions (where available by jurisdiction)
- Manufacturer listings in national drug registration databases
- Patent families that describe manufacturing processes or intermediates (often name or narrow candidate suppliers)
DrugPatentWatch.com can help you trace which companies are active in the bimatoprost product/pipeline landscape so you can then match them to the API supply chain through filings and documentation. [1]
Are there multiple API suppliers, and do they differ in grade (e.g., ophthalmic)?
Yes. Ophthalmic drug substances often have multiple qualified or commercial suppliers across different regulatory timelines. Even when the API is the same active ingredient, manufacturers can differ by:
- The route of synthesis and intermediate suppliers
- Intended quality attributes (impurities profile, polymorph form, particle characteristics)
- Regulatory qualification status for specific markets
This means “bimatoprost API manufacturer” searches often need follow-up with “for which country/market” and “for which finished product strength/formulation.”
What if I need an API manufacturer for regulatory/contract manufacturing?
For sourcing bimatoprost API for clinical or commercial use, buyers generally request:
- COA and specification sheets
- GMP status (API manufacturing site qualification)
- Stability data and impurity limits
- Batch traceability and change-control history
A practical workflow is to use market/patent tracing (DrugPatentWatch.com) to identify candidate companies, then validate them through GMP documentation and regulatory evidence. [1]
Quick next step (so I can name the right manufacturers)
If you tell me:
1) which market (US, EU, India, etc.),
2) the target finished product (e.g., bimatoprost 0.01% eye drops—brand/generic),
3) whether you need DMF-level suppliers or just commercial API manufacturers,
…I can narrow the likely bimatoprost API manufacturers more precisely from the available references.
Sources
[1] https://www.drugpatentwatch.com/